197 related articles for article (PubMed ID: 4049464)
1. Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Procaccianti G; Santucci M; Baruzzi A
Ther Drug Monit; 1985; 7(3):277-82. PubMed ID: 4049464
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
[TBL] [Abstract][Full Text] [Related]
3. Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects.
Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Gobbi G; Cortelli P; Procaccianti G; Baruzzi A
Ther Drug Monit; 1984; 6(4):408-13. PubMed ID: 6542700
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
5. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
Tomson T; Svensson JO; Hilton-Brown P
Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure control.
Theodore WH; Narang PK; Holmes MD; Reeves P; Nice FJ
Ann Neurol; 1989 Feb; 25(2):194-6. PubMed ID: 2919868
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
8. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
[TBL] [Abstract][Full Text] [Related]
9. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
[TBL] [Abstract][Full Text] [Related]
12. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K
Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523
[TBL] [Abstract][Full Text] [Related]
13. The epoxide of carbamazepine.
McKauge L; Tyrer JH; Eadie MJ
Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects.
Kuhnz W; Jäger-Roman E; Rating D; Deichl A; Kunze J; Helge H; Nau H
Pediatr Pharmacol (New York); 1983; 3(3-4):199-208. PubMed ID: 6677873
[TBL] [Abstract][Full Text] [Related]
15. Activities of antioxidant enzymes and formation of the glutathione adduct of hemoglobin (Hb ASSG) in epileptic patients with long-term antiepileptic therapy.
Niketić V; Ristić S; Saicić ZS; Spasić M; Buzadzić B; Stojković M
Farmaco; 1995 Nov; 50(11):811-3. PubMed ID: 8593178
[TBL] [Abstract][Full Text] [Related]
16. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
17. The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy.
Camfield P; Hwang P; Camfield C; Fraser A; Soldin S; al-Quadah AK
Can J Neurol Sci; 1992 May; 19(2):204-7. PubMed ID: 1623447
[TBL] [Abstract][Full Text] [Related]
18. [Alpha 1-acid glycoprotein and carbamazepine].
Bruguerolle B; Bussière H; Jadot G
Rev Neurol (Paris); 1983; 139(11):679-80. PubMed ID: 6677980
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
Vasudev A; Tripathi KD; Puri V
Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
[TBL] [Abstract][Full Text] [Related]
20. Individual and combined antiepileptic and neurotoxic activity of carbamazepine and carbamazepine-10,11-epoxide in mice.
Bourgeois BF; Wad N
J Pharmacol Exp Ther; 1984 Nov; 231(2):411-5. PubMed ID: 6491988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
